Logo-bi
Perspective

1. A prospective highlight on exosomal nanoshuttles and cancer immunotherapy and vaccination
Mohammad A. Rafi, Yadollah Omidi* ORCID
Bioimpacts. 2015;5(3): 117-122. doi: 10.15171/bi.2015.22
PMCID: PMC4597158     PMID: 26457248     Scopus ID: 84944384880    
Article
PDF
XML
Cited By:
16
5
15
Hypothesis

2. Microsurgeon Hirudo medicinalis as a Natural Bioshuttle for Spontaneous Mass Vaccination against Influenza A Virus
Sara Samadi-Shams, Sina Atashpaz, Sajjad Khani*
Bioimpacts. 2011;1(3): 189-191. doi: 10.5681/bi.2011.026
PMCID: PMC3648966     PMID: 23678426     Scopus ID: 84876740375    
Article
PDF
XML
Cited By:
0
0
0
Editorial

3. SARS-CoV-2 vaccine-triggered autoimmunity: Molecular mimicry and/or bystander activation of the immune system
Azam Safary ORCID, Mostafa Akbarzadeh-Khiavi ORCID, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2023;13(4): 269-273. doi: 10.34172/bi.2023.27494
PMCID: PMC10460773     PMID: 37645029     Scopus ID: 85168085723    
Article
PDF
Full Text
XML
Cited By:
2
0
1
Professor Yadollah Omidi has a Ph.D. degree in Pharmaceutical Sciences (2003, Cardiff University, UK). He is currently working as a full professorat Nova Southeastern University College of Pharmacy, Florida. He has consecutively been listedamong top 1% highly cited scientists worldwide by WoS-ESI.
Review

4. The application, safety, and future of ex vivo immune cell therapies and prognosis in different malignancies
Katelyn R. Einloth ORCID, Scott Gayfield, Thomas McMaster, Alexander Didier, Lance Dworkin, Justin Fortune Creeden* ORCID
Bioimpacts. 2023;13(6): 439-455. doi: 10.34172/bi.2023.27521
PMCID: PMC10676524     PMID: 38022382     Scopus ID: 85172806877    
Article
PDF
Full Text
XML
Cited By:
1
0
1

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge